ArticleMolecules (Basel, Switzerland)2026
Cell Reporter-Based Analysis of Anti-Inflammasome Activities of Flavonoids with Distinct Structures.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Flavonoids are natural compounds that have shown promise against chronic inflammation. Despite sharing a common core scaffold, flavonoids exhibit substantial structural heterogeneity, and comparisons of biological activities across subclasses remain limited. These studies are often constrained by the cost and sensitivity limitations of conventional analytical approaches. The main objective of this study was to validate a cell-based reporter system, HEK-Blue IL-1R cells, as an alternative to immunoassays for assessing flavonoid structure-activity relationships on the modulation of inflammasome-driven IL-1β secretion by macrophages. Under mild inflammatory stimulation with lipopolysaccharide (LPS), the reporter displayed sensitive and efficient detection of low-level IL-1β signaling. In a comparative analysis of three flavonoids differing in polarity and glycosylation, quercetin, a polar aglycone, and nobiletin, a methoxylated aglycone, significantly inhibited reporter responses relative to LPS-stimulated controls, with a trend toward greater inhibition detected for quercetin. In contrast, no inhibitory effect was detected for rutin, a glycosylated derivative of quercetin. These findings were consistent with the expression of NLRP3 inflammasome proteins responsible for IL-1β maturation and secretion. Collectively, these results support the potential of flavonoid aglycones against inflammasome-associated inflammation and highlight the HEK-Blue IL-1R reporter system as a sensitive and cost-effective platform for screening IL-1β signaling under conditions of low-grade inflammation.
Indexed as
Identifiers
42796463What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.